m-HBOT (Mild Hyperbaric Oxygen Therapy)

m-HBOT uses pressures below 1.5 ATA, typically around 1.3 ATA , to deliver hyperbaric therapy. The advantages of using these lower pressures is that they can still deliver very high oxygen levels into the body, but with an impeccable safety record. This application of HBOT has been around for a good 20 years and its growth in the hyperbaric community is growing in exponentially. Here are the following reasons:

  • Oxygen concentrators can be used with pressures below 1.5 ATA. The benefits of using oxygen concentrators is that (depending on the model) they can be used to deliver about 93% to 95% oxygen, without the risks of high pressure oxygen cylinders. This adds to the safety of the procedure, while reducing the unnecessary costs of buying oxygen
  • The extra oxygen delivered into the body is in the blood plasma. As previously discussed, the benefits of being transported in plasma is that the oxygen is not tightly bound to red blood cells. Now these molecules can easily and freely travel through the circulatory system, getting to areas where red blood cells may be restricted in flow. This is most likely the major factor that accounts for the many benefits that have been reported with hyperbaric delivery.
  • More and more clinics, doctors and health practitioners are combining their expert skills, alongside the higher oxygen levels generated through m-HBOT, and reporting excellent clinical outcomes.
  • The reported benefits from clinics, doctors, and other health practitioners keeps growing. and is gaining widespread acceptance
  • Media coverage continues to spotlight this procedure, with a continuous influx of news stories and reports referencing m-HBOT